Quinn J P, Holbrook N, Levens D
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892.
Mol Cell Biol. 1987 Aug;7(8):2735-44. doi: 10.1128/mcb.7.8.2735-2744.1987.
The gibbon ape leukemia virus (GALV) contains enhancer activity within its long terminal repeat. In the GALV Seato strain this activity resides in a 48-base-pair (bp) repeated element. We demonstrate the existence of a cellular protein which binds in this region of the Seato strain. A sensitive method for enriching protein-DNA complexes from crude extracts coupled with exonuclease and DNase footprint analysis revealed the specific binding of this protein to a 21-bp region within each repeated element. A 22-bp oligonucleotide fragment defined solely by the 21-bp footprint binds a protein in vitro and displays enhancer activity in vivo, suggesting that this protein is a major determinant of GALV enhancer activity. The protein is present in three cell lines which are positive for enhancer activity and is not detected in Jurkat cells, which are negative for enhancer activity. Only GALV long-terminal-repeat variants which support high levels of enhancer activity in vivo compete with this protein for specific binding in vitro, suggesting a potential role for the protein in determining enhancer activity. This protein binding is not inhibited by competition with heterologous retroviral enhancers, demonstrating that it is not a ubiquitous retroviral enhancer binding protein.
长臂猿白血病病毒(GALV)在其长末端重复序列中含有增强子活性。在GALV西托株中,这种活性存在于一个48碱基对(bp)的重复元件中。我们证明了存在一种能与西托株的该区域结合的细胞蛋白。一种从粗提物中富集蛋白质 - DNA复合物并结合核酸外切酶和DNase足迹分析的灵敏方法,揭示了这种蛋白质与每个重复元件内一个21 bp区域的特异性结合。仅由21 bp足迹定义的一个22 bp寡核苷酸片段在体外能结合一种蛋白质,并在体内显示出增强子活性,这表明这种蛋白质是GALV增强子活性的主要决定因素。该蛋白质存在于三种对增强子活性呈阳性的细胞系中,而在对增强子活性呈阴性的Jurkat细胞中未检测到。只有在体内支持高水平增强子活性的GALV长末端重复序列变体,在体外能与这种蛋白质竞争特异性结合,这表明该蛋白质在决定增强子活性方面可能发挥作用。这种蛋白质结合不受与异源逆转录病毒增强子竞争的抑制,表明它不是一种普遍存在的逆转录病毒增强子结合蛋白。